Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate [Yahoo! Finance]
Prothena Corporation plc - Ordinary Shares (PRTA)
Last prothena corporation plc - ordinary shares earnings: 2/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.prothena.com
Company Research
Source: Yahoo! Finance
PRX019 is the second candidate that has been in-licensed by Bristol Myers under its existing collaboration agreement with PRTA. Prothena anticipates initiating an early-stage study of the candidate by the end of 2024. Bristol Myers' decision to exercise its option for the exclusive global license for PRX019 follows the FDA clearance of Prothena's investigational new drug application for the candidate in December 2023. For the time being, PRX019 has an undisclosed target. The collaboration agreement allows BMY to expand its neurodegenerative disease pipeline. Priothena's shares gained 2.4% in the after-market hours on May 28, as the investors cheered the encouraging news. Year to date, the stock has plunged 45.1% compared with the industry's 5.7% decline. Image Source: Zacks Investment Research Per the terms of the licensing agreement, Prothena will receive an upfront payment of $80 million from Bristol Myers for exclusive global rights to PRX019. Furthermore, PRTA also r
Show less
Read more
Impact Snapshot
Event Time:
PRTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTA alerts
High impacting Prothena Corporation plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRTA
News
- ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal [Yahoo! Finance]Yahoo! Finance
- Prothena to Participate in Upcoming Healthcare ConferencesBusiness Wire
- A New Era For Alzheimer's Disease May Be Around The Corner [Forbes]Forbes
- What Makes Prothena (PRTA) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks [Yahoo! Finance]Yahoo! Finance
PRTA
Earnings
- 8/8/24 - Beat
PRTA
Sec Filings
- 8/8/24 - Form S-8
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- PRTA's page on the SEC website